[Repair of cartilage defects via matrix-associated autologous chondrocyte immigration]
Wild C
Record ID 32013000918
German
Authors' objectives:
Several mechanical methods, such as microfracture, debridement and/or lavage, mosaicplasty, but also the more complex method of tissue engineering - autologeous chondroyte implantation - are clinically applied for the treatment of chondral and osteochondral lesions of the knee. This report evaluates whether the implantation of a ready-made cell-free collagen-typ Imatrix (CaReS®-1S) leads to better results than these established methods.
Authors' recommendations:
The inclusion of CaReS®-1S into the hospital benefit catalogue is not recommended. The currently available evidence is not sufficient to evaluate the efficacy and safety of the implantation of CaReS®-1 in comparison to standard interventions. We recommend a re-evaluation once controlled clinical studies have become available.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://eprints.hta.lbg.ac.at/1002/#
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Austria
MeSH Terms
- Chondrocytes
- Regeneration
- Transplantation, Autologous
Contact
Organisation Name:
Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address:
Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name:
tarquin.mittermayr@aihta.at
Contact Email:
office@aihta.at
Copyright:
Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.